Previous Article | Next Article ![]()
Journal of Virology, April 2001, p. 3230-3239, Vol. 75, No. 7
Institute for Gene Therapy and Molecular
Medicine,1 Department of Physiology and
Biophysics,2 and Department of
Microbiology,3 Mount Sinai School of
Medicine, New York, New York 10029
Received 3 October 2000/Accepted 2 January 2001
The unique ability of adeno-associated virus type 2 (AAV) to
site-specifically integrate its genome into a defined sequence on human
chromosome 19 (AAVS1) makes it of particular interest for
use in targeted gene delivery. The objective underlying this study is
to provide evidence for the feasibility of retargeting site-specific
integration into selected loci within the human genome. Current models
postulate that AAV DNA integration is initiated through the
interactions of the products of a single viral open reading frame,
REP, with sequences present in AAVS1 that
resemble the minimal origin for AAV DNA replication. Here, we present a cell-free system designed to dissect the Rep functions required to
target site-specific integration using functional chimeric Rep proteins
derived from AAV Rep78 and Rep1 of the closely related goose
parvovirus. We show that amino-terminal domain exchange efficiently
redirects the specificity of Rep to the minimal origin of DNA
replication. Furthermore, we establish that the amino-terminal 208 amino acids of Rep78/68 constitute a catalytic domain of Rep sufficient
to mediate site-specific endonuclease activity.
Adeno-associated virus type 2 (AAV)
has drawn much attention as a potential vector for human gene therapy.
Advantages include its apparent lack of pathogenicity, its capacity to
infect many cell types, and, notably, the ability of the wild-type (wt)
virus to site-specifically integrate into a region on chromosome 19 known as AAVS1 (19q13.4) (14, 26-28, 35-37,
47). Integration, and thus the establishment of latency, is
thought to occur preferentially over productive replication in the
absence of coinfection of the host cell by a helper virus (3, 4,
8, 18).
The AAV genome is linear, single stranded, and flanked on either side
by inverted terminal repeats (ITRs) (45, 53). Palindromic sequences within the ITRs allow for the formation of hairpin secondary structures, which contain the viral origins of replication (5, 15, 17, 34, 38, 53). The minimal AAV DNA replication origin
(AAVori) is organized into three segments: the Rep binding site (RBS),
the terminal resolution site (TRS), and a spacer region separating the
RBS from the TRS (Fig. 1A and
2B). The RBS coordinates the
sequence-dependent recruitment of Rep to the origin (11), where it can then deliver a strand-specific nick at the TRS (23, 24). The spacer region has been implicated in favorably
positioning the TRS so that it is efficiently nicked by the Rep protein
(6). Interestingly, within AAVS1 is a region
homologous to the minimal AAV origin in that it also contains a TRS and
an RBS. Rep interaction with the minimal origin sequence in
AAVS1 (57, 62) is required for site-specific
integration (36, 63), thereby suggesting that Rep-mediated
DNA replication may be linked to site-specific integration (Fig. 1B).
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.7.3230-3239.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Amino-Terminal Domain Exchange Redirects
Origin-Specific Interactions of Adeno-Associated Virus Rep78 In
Vitro
![]()
ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

View larger version (12K):
[in a new window]
FIG. 1.
Schematic representation of the Rep-specific origins
within the viral ITR (A) and in AAVS1 (B). See text for a
more detailed discussion.

View larger version (45K):
[in a new window]
FIG. 2.
Schematic representation of protein constructs and
substrates used in this study. (A) Parental, chimeric, and truncated
Rep proteins. Shaded areas correspond to regions derived from GPV Rep1.
Numbers indicate the number of amino acids within each domain; letters
indicate the amino acid at a junction or truncation. Putative functions
of conserved domains are also noted. (B) Synthetic oligonucleotide
substrates used in this study. The TRS and RBS are indicated. Overlined
and underlined sequences are those that are added by Klenow polymerase
for either incorporation of radioactive nucleotides or blunt end
ligations. RS1 is an unrelated sequence used as a control substrate.
Sequences of the chimeric origins were derived from AAV and GPV
sequences as indicated.
Mechanistically, the initial steps of both AAV DNA replication and AAV site-specific integration are thought to be similar (25, 36). In this model, Rep78/68 initiates replication at the viral origin by nicking the TRS in a site- and strand-specific manner, generating a 3' primer for replication. This event is followed by unidirectional replication and displacement of the nicked strand (Fig. 1A) (2). During the process of integration, it is presumed that the chromosomal origin sequence within AAVS1 is also targeted and nicked by means of interactions between Rep-RBS and TRS (37, 57, 67). A prerequisite for the establishment of integration is that limited DNA replication must be possible, once a primer is generated, despite the absence of helper virus functions. This assumption is supported by the results of cell-free DNA replication assays which use recombinant Rep and extracts from cells which are not infected by helper virus (42, 59, 61). Under these conditions, Rep-directed DNA replication is not processive (59, 60). This lack of processivity may result in template strand switches of the replication machinery, potentially generating the cellular-viral DNA junctions observed at sites of AAV integration (25, 36).
Collectively, these observations have made it apparent that Rep is responsible for the specificity of the AAV DNA integration event. Therefore, alteration of the Rep domain(s) responsible for its origin specificity could allow for the possibility of retargeting integration to different genomic loci. However, in order to establish retargeted integration, the functional domains responsible and sufficient for Rep's interaction with the minimal AAV DNA replication origin must be determined.
Of the four REP gene products (Rep78, -68, -52, and -40), Rep78 and -68 are best studied. It has been demonstrated that they are required for virtually every step of the viral life cycle, including DNA replication (20, 55), site-specific integration (1, 37, 54), rescue of integrated genomes, and regulation of both viral and cellular promoters (19, 21, 22, 30-33, 39, 44). Biochemical activities consistent with mediating origin-dependent replication have been characterized: specific binding to RBS-containing substrates (10, 24, 40, 41, 46, 62), nucleoside triphosphate-dependent DNA and DNA-RNA helicase activities (23, 24, 29, 50, 51, 58, 64, 65) and site-specific endonuclease activity at the TRS (23, 24).
Mutational analyses have revealed possible domain boundaries suggesting a separation of the multiple Rep activities (Fig. 2A). With respect to Rep's origin binding capability, studies demonstrating that Rep40 and Rep52, which lack the N terminus of Rep78/68, do not bind the AAV origin, provided the first suggestion that origin binding activity may be associated with this region (24). Furthermore, McCarty et al. (39) have proposed that amino acids 134 to 242 and 415 to 490 are required for specific binding to ITR substrates. In addition to these regions, residues 25 to 62, 88 to 113, and 346 to 400 have also been implicated in specific ITR binding (66). Extending these studies, Urabe et al. (56) undertook charged-to-alanine scanning mutagenesis of the Rep78 amino terminus, the results of which indicated the involvement of the N terminus in ITR binding, endonuclease activity, and thus the ability of these mutants to support integration. That the amino terminus itself may be sufficient for site-specific nicking activity has been recently demonstrated by Davis et al. (13), who earlier implicated tyrosine 156 in endonuclease activity (12). Smith and Kotin subsequently further implicated this tyrosine residue in both endonuclease and ligase activities (49). These studies are in direct contradiction to a study by Gavin et al. (16), who implicated aspartate 412, and thus the carboxy terminus of the protein, in mediating the nicking event.
Although mutational analyses have contributed much to our understanding of Rep function, definite domain boundaries have yet to be established. This is largely because loss of function due to a specific mutation could be attributed either to the replacement of a critical amino acid or, more generically, to the overall misfolding of a protein domain. To overcome this problem, we have chosen to approach domain mapping by generating functionally active AAV/goose parvovirus (GPV) chimeric Rep proteins. GPV is an autonomous parvovirus but nevertheless encodes a regulatory protein, Rep1, which is highly homologous in both sequence and biochemical activity to AAV Rep78 (Fig. 2A) (48, 68). Both proteins have specific DNA binding affinities for their respective origin substrates, helicase activity which maps to the central region of the protein, and C-terminal Zn finger motifs. Furthermore, the GPV origin, specifically recognized by Rep1, is organized similarly to the minimal AAV origin, in that it consists of a putative TRS and an RBS separated by a spacer region (Fig. 2B) (48, 68). Despite this high degree of similarity, GPV Rep1 is capable of mediating helper-independent replication within its host organism, in contrast to AAV Rep78 (7).
Functional chimeric Rep mutants were generated through N-terminal domain swapping based on the homologies between AAV Rep78 and GPV Rep1 (Fig. 2A). In one case, amino-terminal domain swapping between AAV Rep78 and the corresponding domain of GPV Rep1 resulted in a chimeric protein with biochemical activities comparable to those of the wild-type proteins. Intriguingly, the origin-specific interactions of this chimeric protein were determined solely by its N terminus as demonstrated by DNA binding and cell-free DNA replication assays. The chimera's ability to mediate DNA replication implied that the N-terminal domain might also be responsible for the site-specific endonuclease activity. Indeed, further study using N-terminal truncation mutants showed that this region constitutes a catalytic domain in and of itself which can be truncated to 187 N-terminal residues while still retaining specific origin binding and endonuclease activities.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Materials.
All restriction enzymes and Klenow fragment
(3'
5' Exo
) were obtained from New England Biolabs,
Inc., except for Pfu polymerase, which was from Stratagene.
pET16b and pET15b vectors and respective protein expression systems
were from Novagen. HiTrap chelating columns, ATP, deoxynucleoside
triphosphates, and poly(dIdC) were obtained from Pharmacia. Synthetic
oligonucleotides were made by Gene Link and Sigma-Genosys.
[
-32P]dCTP and [
-32P]ATP was
purchased from Amersham.
Cloning of Rep constructs.
Construction of pHisRep78 and
pHisRep1, encoding the His-tagged parental proteins Rep78 and Rep1,
respectively, was as previously described (48). For
Rep78N208
, a single product was amplified by Pfu DNA
polymerase using primer 1 (5'-CATCATCATCATCACAGCAGCG-3'), primer 2 (5'-CGCAGGTCACAGTGTGTCAATTCTGATTCTCTTTGTTCTGCT-3'),
and pHisRep78/16b as the template. In primer 2, nucleotides (nt)
at positions 20 to 42 corresponded to nt 922 to 944 in the wt AAV genome, followed by an opal mutation directly adjacent to amino acid
208 of the Rep open reading frame and a DraIII site. The resulting product was cut with NdeI and DraIII
and ligated to pHisRep78/16b cut with the same enzymes. For
Rep78N208
, the sequence between the NdeI and
BlpI sites was subsequently recloned into a pET15b vector,
which later allowed for efficient thrombin cleavage of the His tag. The
same strategy was applied to the cloning of Rep78R187
, using primer
1 (above), primer 3 (5'-CGCAGGTCACAGTGTGTCACCGTTTACGCTCCGTGAGATTC-3'), and
pHisRep78/15b as the template. Primer 3 is similar to primer 2 in that
nt 20 to 41 corresponded to the wt AAV genome (nt 860 to 881), followed
by an opal mutation directly adjacent to the codon for arginine 187 of
the Rep open reading frame and a DraIII site. This PCR
fragment was directly cloned into a pET15b vector for later removal of
the His tag. Overlapping PCR mutagenesis was used as previously
described (48) clone the chimeric constructs, with the
following modifications. For Rep78/1V232, two separate products were
amplified using (i) primer A (5'-CATCATCATCATCACAGCAGCG-3'), primer A' (5'-GTTATCCCCATTTCCACGAGCCA-3') and
pHisRep78/16b as the template and (ii) primer B
(5'-TGGCTCGTGGAAATGGGGATAAC-3'), primer B'
(5'-CCTCAAGACCCGTTTAGAGGC-3'), and pHisRep1/16b as the template. In primer A', nt 1 to 11 correspond to nt 1242 to 1252 of
the wt GPV genome and nt 12 to 23 correspond to nt 1010 to 1021 in the
wt AAV genome. In primer B, nt 1 to 12 correspond to AAV nt 1010 to
1021, while nt 13 to 23 correspond to GPV nt 1242 to 1252. The
resulting PCR products were gel purified, combined, and reamplified in
the presence of primers A and B'. This full-length product of 2.1 kb
was then cut with SacII and BamHI and ligated to
pHisRep78/16b, which was cut with the same enzymes and gel purified.
Rep1/78E235 was cloned in a similar manner as its counterpart using (i)
primer C (5'-ATTGTGAGCGGATAACAATTCCC-3'), primer C' (5'-GTAATCCCCTTTTCAATGAGCCA-3'), and pHisRep1/16b as the
template and (ii) primer D (5'-TGGCTCATTGAAAAGGGGATTAC-3'),
primer D' (5'-GGTGTTGGAGGTGACGATCAC-3'), and
pHisRep78/16b as the template. In primer C', nt 1 to 11 correspond to
GPV nt 1020 to 1030, while nt 12 to 23 correspond to AAV nt 1230 to
1241. In primer D, nt 1 to 12 correspond to GPV nt 1230 to 1241, and nt
12 to 23 correspond to AAV nt 1020 to 1030. The full-length product of
1.4kb was cut with NsiI and DraIII and ligated to
pHisRep1/78K343 cut with the same enzymes. pHisRep1/78K343 is a
chimeric construct, previously cloned in our laboratory, consisting of
the Rep1 amino terminus and Rep78 carboxy terminus joined at a common
BpuAI site. For Rep78N208
(Y156F), two separate PCR
products were generated using (i) primer 1 and primer 4 (5'-GGGGAGCAAGAAATTGGGGATG-3') and (ii) primer 5 (5'-CAGAGAGAGTGTCCTCGAGCC-3') and primer 6 (5'-CATCCCCAATTTCTTGCTCCCC-3'), with
pHisRep78N208
/15b as template (primers 4 and 6 are
complementary and correspond to AAV 776 to 797 with a mutation
occurring in the codon coding for tyrosine 156 of the Rep open reading
frame, resulting in a point mutation at this amino acid position to
phenylalanine). These two fragments were combined and amplified using
primer 1 and primer 5, cut with SacII and DraIII,
and ligated to pHisRep78/15b cut with the same enzymes. In all cases,
products generated by PCR were verified by sequencing.
Protein purification.
Rep78, Rep1, chimeric Rep constructs
(cloned into the pET16b vector), and Rep78N208
and Rep78R187
(cloned into the pET15b vector) were expressed in BL21(DE3) strain
Escherichia coli carrying pLysS. The resulting His-tagged
proteins were isolated according to the manufacturer's instructions
with the following modifications. Briefly, cultures were induced with 1 mM IPTG (isopropyl-
-D-thiogalactopyranoside) for
1.5 h at 37°C (for Rep78, Rep78N208
, and Rep78R187
),
2 h at 37°C [for Rep78/1V232 and Rep78N208
(Y156F)],
1.5 h at 30°C (for Rep1), or 4 h at 20°C (for
Rep1/78E236). Induced cells were pelleted and freeze-thawed prior to
sonication in commercial binding buffer containing protease inhibitors
(Novagen). Cell lysates were loaded onto a 1-ml nickel affinity column
and washed with increasing imidazole concentrations up to 100 mM (for
Rep78, Rep78N208
, and Rep78R187
), 60 mM [for Rep78/1V232 and
Rep78N208
(Y156F)], or 200mM (for Rep1 and Rep1/78E236). Proteins
were eluted in buffer containing 1 M imidazole (for Rep78 and
Rep78/1V232), 500 mM imidazole [for Rep1, Rep1/78E236, Rep78R187
,
and Rep78N208
(Y156F)], or 400 mM imidazole (for Rep78N208
).
The eluted proteins were then desalted over a Sephadex G-25 column
which was equilibrated in protein storage buffer (25 mM Tris · Cl [pH 7.5], 0.1 mM EDTA, 1 mM dithiothreitol [DTT], 0.01% NP-40,
and 20% glycerol) containing 50 mM NaCl (for Rep1 and Rep78/1V232) or
250mM NaCl (for Rep78 and Rep1/78E236). Rep78N208
,
Rep78N208
(Y156F), and Rep78R187
were desalted into thrombin
buffer and digested to remove the His tag. Following digestion, each
protein was reloaded onto a nickel affinity column and the flowthrough
was reequilibrated in protein storage buffer containing either 250 mM
NaCl [for Rep78N208
and Rep78N208
(Y156F)] or 200 mM NaCl (for
Rep78R187
). Determination of salt concentrations in the storage
buffer for each protein was based on optimization performed with the
parental Rep proteins (48). All proteins were frozen as
aliquots in liquid N2 and stored at
80°C. Protein
concentrations were determined using the Bio-Rad protein assay reagent
as per the manufacturer's instructions.
Generation of substrates. Substrates for electrophoretic mobility shift assays (EMSA) and helicase assays were radiolabeled using Klenow fragment as previously described (48). The replication substrate, pBSori (see Fig. 5A), was made by cloning the respective origin into pBluescript via XbaI and SalI restriction sites. The plasmid was then linearized by digestion with NaeI, phenol-chloroform extracted, ethanol precipitated, and resuspended in 0.5× TE (5 mM Tris · Cl [pH 8.0], 0.5 mM EDTA [pH 8.0]). Endonuclease assay substrates were generated by first kinase labeling the TRS-containing oligonucleotide and then annealing the labeled oligonucleotide to the appropriate complementary strand.
DNA helicase assay. The DNA helicase assay was performed as described previously (48). In short, in a reaction volume of 10 µl, 50 or 100 ng of protein was incubated for 30 min at 37°C in the presence of 50 fmol of Klenow-labeled RS1 (Fig. 2B). Each protein was adjusted to 50 ng/µl in the appropriate storage buffer, and a total of 2 µl of protein and/or buffer was added to each reaction mixture. Reactions were terminated by quick-chilling on an ice water bath. After the addition of 3 µl of loading buffer, a total of 10 µl was loaded onto an 8% polyacrylamide gel. The electrophoresed gel was then fixed, dried, and visualized on a STORM860 PhosphorImager (Molecular Dynamics). Quantification of PhosphorImager data was performed using Imagequant version 1.11 software (Molecular Dynamics).
Cell-free replication assay.
Cell-free replication assays
were performed as described previously (48). Reaction
mixtures containing 100 ng of origin template DNA were preincubated for
3 h prior to addition of [
-32P]dCTP and Rep
protein to minimize incorporation of labeled dCTP through DNA repair
mechanisms. Upon addition of [
-32P]dCTP and 75 ng of
Rep protein, reaction mixtures were incubated at 37°C for 16 h,
reactions were terminated by passage over a Sephadex G-50 spin column,
and the products were digested with proteinase K (Boerhinger Manhinem).
Replication products were analyzed by electrophoresis on 0.8% agarose
gels in 90 mM Tris · borate (pH 8.3)-2 mM EDTA (1× TBE) and
visualized as in the EMSA and helicase assays.
EMSA. Except where indicated, assays were performed as follows. In a total reaction volume of 14 µl, 100 ng of protein was incubated with 30 fmol of radiolabeled DNA in a buffer consisting of 0.25× TBE, 14.3 mM NaCl, 0.9 mM DTT, 0.04% NP-40, 400 ng of poly(dIdC), and 3 µl of loading buffer (40% sucrose, 1% xylene cyanol, and 1% bromophenol blue in 0.25× TBE). After incubation for 10 min at room temperature, 7 µl of the total reaction volume was loaded onto a 6% polyacrylamide gel in 0.25× TBE, incubated for an additional 10 min, and run at 18 V/cm at room temperature. Electrophoresed gels were then fixed in 10% trichloroacetic acid, dried, and visualized as in the helicase assay.
Endonuclease assay. Nicking assays were performed as previously described (6, 23), with minor modifications. Briefly, 20-µl reaction mixtures contained 25 mM HEPES · KOH (pH 7.5), 1 mM DTT, 200 ng of bovine serum albumin, 5 fmol of 5'-labeled DNA, and, where indicated, 1mM ATP and metal cofactor. Typically, 1 pmol of Rep78 or Rep78(K340H) was added to the reaction mixtures, while truncation mutants required larger amounts in order for activity to be observed, usually 20-40 pmol. After incubation for 1 h at 37°C, reaction mixtures were proteinase K digested for 1 h at 50°C and ethanol precipitated in the presence of 2 µg of sonicated salmon sperm DNA (as carrier) and approximately 10 mM MgCl2 (to facilitate precipitation of single-stranded reaction products). Precipitated DNA was resuspended in loading buffer, heated to 95°C for 5 min, and fractionated on either 15 or 12% polyacrylamide gels in 1× TBE containing 50% urea. Bands were visualized using a STORM860 PhosphorImager (Molecular Dynamics).
| |
RESULTS |
|---|
|
|
|---|
Design, overexpression, and isolation of enzymatically active chimeric Rep proteins. In order to identify a minimal origin interaction domain and to test the feasibility of redirecting origin specificity, chimeric AAV/GPV Rep proteins were generated. Chimeric proteins were constructed in which the N-terminal origin binding domain of Rep78 was replaced by the corresponding domain from GPV Rep1 (designated Rep1/78E235) and vice versa (designated Rep78/1V232) (Fig. 2A). The chimeras were expressed as His-tagged fusion proteins in E. coli and isolated as described in Materials and Methods. It was our expectation that in each chimera, swapping of a putative origin interaction domain would redirect the origin specificity of the parent protein to that specified by the N terminus of the donor. The junctions within the chimeric proteins were designed to be at or near the initiation methionines of Rep52 and -40 (M225 of Rep78 and M236 of Rep1), at a position where the relatively low homology of the N terminus transitions into the highly conserved central core domain (V232 of Rep78 and E235 of Rep1) (Fig. 2A).
To test whether these chimeras retained enzymatic activity, several functional assays were performed. On an unrelated double-stranded substrate (RS1) (Fig. 2B), both chimeras maintained helicase activity comparable to that of the proteins from which they were derived, indicating that the helicase domains of the chimeric proteins were folded correctly (Fig. 3). Dominant-negative variants (containing a mutation of the nucleotide binding motif) of Rep78 (K340H) (29) and Rep1 (K342H) (48) purified in a manner similar to that for the chimeric proteins did not possess helicase activity (data not shown), demonstrating that the activity was not attributable to a copurifying contaminant.
|
|
The N terminus of GPV Rep1 effectively redirects AAV
Rep78-mediated, origin-dependent DNA replication in vitro.
One
objective of the study presented here was to test the feasibility of
redirecting the origin specificity of the AAV Rep protein as a first
step in establishing retargeted, site-specific integration. AAV DNA
replication can be initiated by Rep on two different templates, which
differ in whether a free 3' end is already available to serve as a
primer (as in an initial AAV infection [Fig. 1A]) or must be produced
through Rep endonuclease activity (as in the terminal resolution, viral
integration, and rescue of integrated viral genomes [Fig. 1B]). We
examined replication as mediated by the chimeric proteins using
substrates that would require Rep-mediated endonuclease activity at the
TRS for formation of a 3' primer, thus resembling the substrate
involved in site-specific integration. These substrates (Fig.
5A) were constructed by cloning the
AAVori or the GPVori (Fig. 2B) into pBluescript, after which the
plasmid was linearized approximately 300 bp 5' to the origin sequence
(48). As shown in Fig. 5B, the proteins used in the replication assays are highly purified and show slightly different mobilities. The results of these assays are shown in Fig. 5C. Each
parental Rep protein is able to initiate DNA replication efficiently
from its cognate origin (Fig. 5C, lanes 3 and 6), while few or no
full-length replication products were observed when the opposite
origins were used to direct replication (Fig. 5C, lanes 4 and 5). A
considerable amount of short replication products was seen with Rep78
on GPVori (lane 5). While these molecules have not yet been
characterized, their presence indicates that limited Rep78-dependent
DNA replication can be initiated on a GPVori-containing substrate. The
extent and specificity of replication observed with Rep1/78E235 (Fig.
5C, lanes 1 and 7) were comparable to those observed with Rep1 on the
GPVori substrate tested (lanes 3 and 8). While this chimera efficiently
replicates the GPVori substrate, it does not replicate the AAVori
substrate (Fig. 5C, lane 2), indicating that the origin specificity of
Rep-mediated DNA replication can be altered by exchange of the
N-terminal origin specificity domain. No replication was observed using
Rep78/1V232 (data not shown).
|
The N-terminal 208 amino acids of Rep78 are sufficient for specific
origin binding.
We have observed that the specificities for both
RBS binding and TRS endonuclease activity reside in the amino-terminal
domain, suggesting the possibility that the amino terminus itself
constituted an additional Rep catalytic domain responsible for
endonuclease activity. This hypothesis was also supported by previously
published observations that an amino-terminal tyrosine residue (Tyr156) is involved in the attachment of Rep to the 5' end of the nicked substrate (12, 49). In order to determine the possible
position of the physical domain border so that this activity could be
biochemically isolated, several approaches were employed. First, it has
been proposed that the N-terminal 225 amino acids of Rep78/68 are
responsible for RBS binding, since Rep52 and Rep40, variants which lack
these residues, do not bind the origin DNA (24). We
hypothesized that the boundary of the endonuclease domain was located
proximal to the initiating methionine of Rep52, in a region of low
homology between AAV and other parvoviruses, such as adeno-associated
virus type 5 (9) and GPV (68). A ClustalW
alignment (Blosum 30 matrix; open gap penalty of 10; extended gap
penalty of 0.1) between the Rep proteins of GPV and muscovy duck
parvovirus (reference 68 and data not shown) showed that
these two proteins are highly homologous (97.5% identical and 99.5%
similar within the N-terminal 200 amino acids) yet diverge
significantly between amino acids 201 and 210 (2 out of 10 amino acids
identical; 4 out of 10 conserved; 4 out of 10 different), suggesting a
potential hinge region between two conserved domains. We therefore
constructed a variant, Rep78N208
(Fig. 2A), which is truncated
within this putative linker region at asparagine 208. Limited
proteolysis experiments followed by peptide sequencing were also
performed. Digestion of Rep68 with the unspecific proteases proteinase
K and subtilisin resulted in four major and five minor bands when the
products were separated on a sodium dodecyl sulfate
(SDS)-polyacrylamide gel (data not shown). In order to simplify the
analysis of these experiments, limited proteolysis was performed on
Rep78N208
(Fig. 6). Prior to
proteolysis, the N-terminal His tag was removed by thrombin cleavage
followed by repurification over a nickel affinity column. As shown in
Fig. 6, digestion of Rep78N208
with either proteinase K or
subtilisin resulted in a single species with an apparent molecular mass
of approximately 21 kDa. Subsequent peptide sequencing indicated that
this molecule terminated at amino acid R187 (data not shown), and an
additional truncation variant, Rep78R187
, was also isolated. Both
proteins were tested by EMSA for their ability to specifically bind
AAVori DNA. Figure 7 demonstrates the
ability of Rep78N208
and, to a certain extent, Rep78R187
to
specifically bind AAVori (lanes 2 and 8), as binding was competed by
excess nonradiolabeled AAVori (lanes 3 and 9) but not by an unrelated
sequence, RS1 (lanes 4 and 10). It should be noted that to generate the
shift observed, a sixfold-higher protein concentration was required for
Rep78R187
than for Rep78N208
(Fig. 7, lane 8).
|
|
Amino-terminal endonuclease activity.
To address the
possibility that the N terminus possessed catalytic activity as
suggested by the origin-dependent replication assays, we assayed
Rep78N208
and Rep78R187
for endonuclease activity. Because these
truncation mutants lacked the domains known to be responsible for
helicase activity, we designed partially single-stranded substrates in
which helicase activity would not be required for nicking of the TRS
(6, 52). As Fig. 8A
indicates, wt Rep78 is the only protein tested which can specifically
nick AAVori DNA with a double-stranded TRS in an ATP-dependent manner (lanes 4 to 7). In addition, both Mg2+ and Mn2+
can serve as divalent cations in this reaction. However, once helicase
activity is rendered unnecessary for TRS nicking (by making the TRS
single stranded), Mn2+ is clearly preferred in this
reaction (Fig. 8A, lanes 13 to 16). Rep78N208
has the ability to
nick substrates with a single-stranded TRS (lanes 17 to 20) indicating
that the complete catalytic endonuclease domain of Rep is contained
within the N-terminal 208 amino acids. Note that in the case of the
truncation variants, endonuclease products can be observed only when
the assay is performed in the presence of Mn2+ and not when
it is performed with Mg2+. In order to demonstrate
specificity of this reaction, several controls were included (Fig. 8B).
As predicted, the helicase-negative mutant Rep78(K340H) is able to
mediate site-specific nicking at the single-stranded TRS (Fig. 8B, lane
3). Change of the active tyrosine to a phenylalanine (Y156F) in
Rep78N208
abolishes endonuclease activity. Specificity for nicking
at the TRS was retained, since significant nicking was not observed on
substrates containing mutations within the TRS. As was shown in Fig. 7,
Rep78R187
binds AAVori DNA. Lane 6 in Fig. 8B also demonstrates
site-specific endonuclease activity by this truncation mutant. However,
this activity is markedly reduced in comparison to that of
Rep78N208
, suggesting that the actual domain boundary is better
reflected by Rep78N208
than by this shorter variant.
|
| |
DISCUSSION |
|---|
|
|
|---|
The regulatory Rep proteins of AAV have the ability to mediate site-specific integration of the viral DNA into the human host genome. The integration mechanism is thought to be initiated by means of Rep interactions with a Rep-specific origin of replication present on the human target sequence. To date, three steps have been implicated in Rep-mediated origin interaction: Rep recognition and binding to the RBS is followed by partial unwinding of the origin, thus generating a single-stranded TRS as a target for Rep site-specific endonuclease activity.
The identification of domains necessary and sufficient for the specificity of the origin interactions (and thus targeting of integration) by means of mutational analyses is complicated by the fact that Rep is a multifunctional protein for which a panoply of activities have been described, most recently, ligase activity (49). It is not surprising that most of the Rep mutants documented to date show a loss of multiple functions.
In order to overcome these limitations, we have chosen to approach the identification of the origin interaction domain by generating functionally active chimeric Rep proteins. Amino-terminal domain swapping between AAV Rep78 and the corresponding domain of GPV Rep1 resulted in chimeric proteins with biochemical activities comparable to those of the wt proteins as determined by helicase assays. Furthermore, EMSA experiments using unlabeled origin competitor DNA clearly show that Rep78/1V232 specifically binds AAVori substrates while Rep1/78E235 has a specific affinity to GPVori DNA, essentially demonstrating that origin binding specificity can be altered without the apparent loss of biochemical activity.
To further test the feasibility of N-terminal domain exchange for the alteration of origin interaction specificity by Rep78, cell-free DNA replication experiments were performed with Rep1/78E235. The results obtained from these experiments were intriguing in several respects. First, compared to the GPV origin, replication was markedly reduced with the two chimeric origins, A/G and A/A/G, indicating that the TRS specificity could not be attributed to the central core domain as previously proposed (16). These data suggested that the specificity for both the RBS and TRS was determined by the N-terminal 235 amino acids of the Rep protein. This conclusion was clearly supported when wt origins were compared using parental proteins as well as Rep1/78E235. These data demonstrate that N-terminal domain exchange redirects the origin specificity of Rep78 from AAVori to GPVori, thereby indicating that origin specificity is exclusively determined by the N-terminal Rep domain. However, one surprising finding was that Rep78 was able to initiate significant replication activity on GPVori with the vast majority of products at subtemplate length. While the nature of these molecules is unknown, it might be speculated that Rep78 may be able to assemble a replication complex which is capable of initiating an errant type of DNA replication when provided with a suboptimal origin.
Based on the conclusions from our replication data, we
hypothesized that the Rep N-terminal domain not only was sufficient to
determine origin binding specificity but also contained the necessary
motifs for catalytic endonuclease activity. Two amino-terminal truncation mutants of Rep were generated, Rep78N208
and
Rep78R187
. These proteins bound the AAVori as determined by EMSA.
However, in order to achieve binding, sixfold-greater protein
concentrations were required for Rep78R187
than for Rep78N208
,
indicating that truncation of Rep at R187 had disturbed the integrity
of the origin binding domain. Together with the data generated by
limited-proteolysis analyses, these results suggest that amino acids
187 through 208 form a relatively unstructured region within Rep that
becomes structured in the presence of specific DNA and in this
conformation contributes to the ability of Rep to specifically interact
with the RBS.
Nicking assays using the amino-terminal truncation mutants were
performed using either Mg2+ or Mn2+ on both
fully double-stranded substrates and on substrates in which the TRS
region was single stranded. As expected, fully double-stranded templates were nicked only by full-length Rep78 (i.e., a molecule that
retains an active helicase domain), while no endonuclease activity was
observed with Rep78N208
. When partially single-stranded substrates
were used, both Rep78 and Rep78N208
showed activity, the latter only
in the presence of Mn2+ under these conditions. The
truncation variants required higher concentrations than full-length Rep
in order for endonuclease activity to be observed, which is also
consistent with the EMSA data and may suggest that higher
concentrations of the truncation proteins are required for efficient
RBS interactions. The activity of Rep78R187
was substantially lower
than that of Rep78N208
, but the presence of a faint product band
indicated that the residues required for site-specific nicking were
contained within the N-terminal 187 amino acids of Rep. The
Rep78R187
results suggest that while core catalytic activity can be
retained despite the removal of the additional amino acids present in
Rep78N208
, the integrity of the catalytic domain is rapidly lost.
This latter point is supported by the results of Davis et al.
(13), who observed endonuclease activity with a construct
comprised of the first 200 amino acids of Rep78/68, but at greatly
reduced levels compared to the full-length protein. Thus, we conclude
that asparagine 208 most closely reflects the physical endonuclease
domain boundary.
In summary, our data indicate that the N terminus of Rep constitutes an independent origin interaction domain containing the endonuclease activity required for the initiation of both DNA replication and site-specific integration. Based on our findings, we can now conclude that the wt Rep protein contains three independent metal coordination sites. While it is not clear which divalent cations are used in vivo, in our assays the endonuclease domain can be distinguished from the helicase domain in its Mn2+ dependence. Identification of these residues involved in coordination of the metal ion required for endonuclease activity will provide an idea for the biochemical mechanism for the Rep endonuclease through comparison to other endonuclease families that have been previously characterized (e.g., topoisomerases, recombinase-activating gene proteins [RAGs], integrases, transposases, and bacteriophage replication initiator proteins). Furthermore, cellbased assays can be designed to address the question whether AAV site-specific integration requires DNA replication or, alternatively, whether a site-specific nick introduced by the N terminus is sufficient to initiate this unique recombination event.
We have provided biochemical evidence for the feasibility of retargeting AAV Rep origin specificity through amino-terminal domain exchange with other parvoviruses. Based on the current model for Rep-mediated site-specific integration, our data provide the first evidence that it may be possible to design Rep proteins capable of targeting integration into alternative loci within a human or animal genome.
| |
ACKNOWLEDGMENTS |
|---|
M. Yoon and D. H. Smith contributed equally to this work.
We thank Nathalie Dutheil and Zhen-Qiang Pan for helpful discussions and José Trincão for technical assistance with protein purifications.
This work was supported in part by grants DK55609 and DK57746 (to R.M.L.) and T32AI07647 (M.Y.) from the National Institutes of Health.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institute for Gene Therapy and Molecular Medicine, Mount Sinai School of Medicine, 1 Gustave Levy Pl., Box 1496, New York, NY 10029-6574. Phone: (212) 659-8278. Fax: (212) 849-2437. E-mail: Michael.Linden{at}mssm.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Balague, C., M. Kalla, and W. W. Zhang. 1997. Adeno-associated virus Rep78 protein and terminal repeats enhance integration of DNA sequences into the cellular genome. J. Virol. 71:3299-3306[Abstract]. |
| 2. | Berns, K. I. 1996. Parvoviridae: the viruses and their replication, p. 2173-2197. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven, Philadelphia, Pa. |
| 3. | Berns, K. I., and R. M. Linden. 1995. The cryptic life style of adeno-associated virus. Bioessays 17:237-245[CrossRef][Medline]. |
| 4. | Berns, K. I., T. C. Pinkerton, G. F. Thomas, and M. D. Hoggan. 1975. Detection of adeno-associated virus (AAV)-specific nucleotide sequences in DNA isolated from latently infected Detroit 6 cells. Virology 68:556-560[CrossRef][Medline]. |
| 5. | Bohenzky, R. A., R. B. LeFebvre, and K. I. Berns. 1988. Sequence and symmetry requirements within the internal palindromic sequences of the adeno-associated virus terminal repeat. Virology 166:316-327[CrossRef][Medline]. |
| 6. |
Brister, J. R., and N. Muzyczka.
1999.
Rep-mediated nicking of the adeno-associated virus origin requires two biochemical activities, DNA helicase activity and transesterification.
J. Virol.
73:9325-9336 |
| 7. |
Brown, K. E.,
S. W. Green, and N. S. Young.
1995.
Goose parvovirus an autonomous member of the dependovirus genus?
Virology
210:283-291[CrossRef][Medline].
|
| 8. |
Cheung, A. K.,
M. D. Hoggan,
W. W. Hauswirth, and K. I. Berns.
1980.
Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells.
J. Virol.
33:739-748 |
| 9. |
Chiorini, J. A.,
F. Kim,
L. Yang, and R. M. Kotin.
1999.
Cloning and characterization of adeno-associated virus type 5.
J. Virol.
73:1309-1319 |
| 10. |
Chiorini, J. A.,
S. M. Wiener,
R. A. Owens,
S. R. Kyostio,
R. M. Kotin, and B. Safer.
1994.
Sequence requirements for stable binding and function of Rep68 on the adeno-associated virus type 2 inverted terminal repeats.
J. Virol.
68:7448-7457 |
| 11. | Chiorini, J. A., L. Yang, B. Safer, and R. M. Kotin. 1995. Determination of adeno-associated virus Rep68 and Rep78 binding sites by random sequence oligonucleotide selection. J. Virol. 69:7334-7338[Abstract]. |
| 12. |
Davis, M. D.,
R. S. Wonderling,
S. L. Walker, and R. A. Owens.
1999.
Analysis of the effects of charge cluster mutations in adeno-associated virus Rep68 protein in vitro.
J. Virol.
73:2084-2093 |
| 13. |
Davis, M. D.,
J. Wu, and R. A. Owens.
2000.
Mutational analysis of adeno-associated virus type 2 Rep68 protein endonuclease activity on partially single-stranded substrates.
J. Virol.
74:2936-2942 |
| 14. |
Dutheil, N.,
F. Shi,
T. Dupressoir, and R. M. Linden.
2000.
Adeno-associated virus site-specifically integrates into a muscle-specific DNA region.
Proc. Natl. Acad. Sci. USA
97:4862-4866 |
| 15. | Fife, K. H., K. I. Berns, and K. Murray. 1977. Structure and nucleotide sequence of the terminal regions of adeno-associated virus DNA. Virology 78:475-477[CrossRef][Medline]. |
| 16. |
Gavin, D. K.,
S. M. Young, Jr.,
W. Xiao,
B. Temple,
C. R. Abernathy,
D. J. Pereira,
N. Muzyczka, and R. J. Samulski.
1999.
Charge-to-alanine mutagenesis of the adeno-associated virus type 2 Rep78/68 proteins yields temperature-sensitive and magnesium-dependent variants.
J. Virol.
73:9433-9445 |
| 17. | Gerry, H. W., T. J. Kelly, Jr., and K. I. Berns. 1973. Arrangement of nucleotide sequences in adeno-associated virus DNA. J. Mol. Biol. 79:207-225[CrossRef][Medline]. |
| 18. |
Handa, H.,
K. Shiroki, and H. Shimojo.
1975.
Complementation of adeno-associated virus growth with temperature-sensitive mutants of human adenovirus types 12 and 5.
J. Gen. Virol.
29:239-242 |
| 19. |
Hermonat, P. L.
1994.
Adeno-associated virus inhibits human papillomavirus type 16: a viral interaction implicated in cervical cancer.
Cancer Res.
54:2278-2281 |
| 20. |
Hermonat, P. L.,
M. A. Labow,
R. Wright,
K. I. Berns, and N. Muzyczka.
1984.
Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants.
J. Virol.
51:329-339 |
| 21. | Holscher, C., J. A. Kleinschmidt, and A. Burkle. 1995. High-level expression of adeno-associated virus (AAV) Rep78 or Rep68 protein is sufficient for infectious-particle formation by a Rep-negative AAV mutant. J. Virol. 69:6880-6885[Abstract]. |
| 22. | Horer, M., S. Weger, K. Butz, F. Hoppe-Seyler, C. Geisen, and J. A. Kleinschmidt. 1995. Mutational analysis of adeno-associated virus Rep protein-mediated inhibition of heterologous and homologous promoters. J. Virol. 69:5485-5496[Abstract]. |
| 23. | Im, D. S., and N. Muzyczka. 1990. The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity. Cell 61:447-457[CrossRef][Medline]. |
| 24. |
Im, D. S., and N. Muzyczka.
1992.
Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization.
J. Virol.
66:1119-1128 |
| 25. | Kotin, R. M. 1994. Prospects for the use of adeno-associated virus as a vector for human gene therapy. Hum. Gene Ther. 5:793-801[Medline]. |
| 26. | Kotin, R. M., R. M. Linden, and K. I. Berns. 1992. Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination. EMBO J. 11:5071-5078[Medline]. |
| 27. | Kotin, R. M., J. C. Menninger, D. C. Ward, and K. I. Berns. 1991. Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter. Genomics 10:831-834[CrossRef][Medline]. |
| 28. |
Kotin, R. M.,
M. Siniscalco,
R. J. Samulski,
X. D. Zhu,
L. Hunter,
C. A. Laughlin,
S. McLaughlin,
N. Muzyczka,
M. Rocchi, and K. I. Berns.
1990.
Site-specific integration by adeno-associated virus.
Proc. Natl. Acad. Sci. USA
87:2211-2215 |
| 29. | Kyostio, S. R., and R. A. Owens. 1996. Identification of mutant adeno-associated virus Rep proteins which are dominant-negative for DNA helicase activity. Biochem. Biophys. Res. Commun. 220:294-299[CrossRef][Medline]. |
| 30. |
Kyostio, S. R.,
R. A. Owens,
M. D. Weitzman,
B. A. Antoni,
N. Chejanovsky, and B. J. Carter.
1994.
Analysis of adeno-associated virus (AAV) wild-type and mutant Rep proteins for their abilities to negatively regulate AAV p5 and p19 mRNA levels.
J. Virol.
68:2947-2957 |
| 31. | Kyostio, S. R., R. S. Wonderling, and R. A. Owens. 1995. Negative regulation of the adeno-associated virus (AAV) P5 promoter involves both the P5 Rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein. J. Virol. 69:6787-6796[Abstract]. |
| 32. |
Labow, M. A.,
L. H. Graf, Jr., and K. I. Berns.
1987.
Adeno-associated virus gene expression inhibits cellular transformation by heterologous genes.
Mol. Cell. Biol.
7:1320-1325 |
| 33. |
Labow, M. A.,
P. L. Hermonat, and K. I. Berns.
1986.
Positive and negative autoregulation of the adeno-associated virus type 2 genome.
J. Virol.
60:251-258 |
| 34. |
Lefebvre, R. B.,
S. Riva, and K. I. Berns.
1984.
Conformation takes precedence over sequence in adeno-associated virus DNA replication.
Mol. Cell. Biol.
4:1416-1419 |
| 35. | Linden, R. M., and K. I. Berns. 1997. Site-specific integration by adeno-associated virus: a basis for a potential gene therapy vector. Gene Ther. 4:4-5[CrossRef][Medline]. |
| 36. |
Linden, R. M.,
P. Ward,
C. Giraud,
E. Winocour, and K. I. Berns.
1996.
Site-specific integration by adeno-associated virus.
Proc. Natl. Acad. Sci. USA
93:11288-11294 |
| 37. |
Linden, R. M.,
E. Winocour, and K. I. Berns.
1996.
The recombination signals for adeno-associated virus site-specific integration.
Proc. Natl. Acad. Sci. USA
93:7966-7972 |
| 38. |
Lusby, E.,
K. H. Fife, and K. I. Berns.
1980.
Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA.
J. Virol.
34:402-409 |
| 39. |
McCarty, D. M.,
T. H. Ni, and N. Muzyczka.
1992.
Analysis of mutations in adeno-associated virus Rep protein in vivo and in vitro.
J. Virol.
66:4050-4057 |
| 40. |
McCarty, D. M.,
D. J. Pereira,
I. Zolotukhin,
X. Zhou,
J. H. Ryan, and N. Muzyczka.
1994.
Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein.
J. Virol.
68:4988-4997 |
| 41. |
McCarty, D. M.,
J. H. Ryan,
S. Zolotukhin,
X. Zhou, and N. Muzyczka.
1994.
Interaction of the adeno-associated virus Rep protein with a sequence within the A palindrome of the viral terminal repeat.
J. Virol.
68:4998-5006 |
| 42. |
Ni, T. H.,
W. F. McDonald,
I. Zolotukhin,
T. Melendy,
S. Waga,
B. Stillman, and N. Muzyczka.
1998.
Cellular proteins required for adeno-associated virus DNA replication in the absence of adenovirus coinfection.
J. Virol.
72:2777-2787 |
| 43. |
Owens, R. A.,
M. D. Weitzman,
S. R. Kyostio, and B. J. Carter.
1993.
Identification of a DNA-binding domain in the amino terminus of adeno-associated virus Rep proteins.
J. Virol.
67:997-1005 |
| 44. | Pereira, D. J., and N. Muzyczka. 1997. The cellular transcription factor SP1 and an unknown cellular protein are required to mediate Rep protein activation of the adeno-associated virus p19 promoter. J. Virol. 71:1747-1756[Abstract]. |
| 45. |
Ruffing, M.,
H. Heid, and J. A. Kleinschmidt.
1994.
Mutations in the carboxy terminus of adeno-associated virus 2 capsid proteins affect viral infectivity: lack of an RGD integrin-binding motif.
J. Gen. Virol.
75:3385-3392 |
| 46. | Ryan, J. H., S. Zolotukhin, and N. Muzyczka. 1996. Sequence requirements for binding of Rep68 to the adeno-associated virus terminal repeats. J. Virol. 70:1542-1553[Abstract]. |
| 47. | Samulski, R. J., X. Zhu, X. Xiao, J. D. Brook, D. E. Housman, N. Epstein, and L. A. Hunter. 1991. Targeted integration of adeno-associated virus (AAV) into human chromosome 19. EMBO J. 10:3941-3950[Medline]. (Erratum, 11:1228, 1992.) |
| 48. |
Smith, D. H.,
P. Ward, and R. M. Linden.
1999.
Comparative characterization of Rep proteins from the helper-dependent adeno-associated virus type 2 and the autonomous goose parvovirus.
J. Virol.
73:2930-2937 |
| 49. |
Smith, R. H., and R. M. Kotin.
2000.
An adeno-associated virus (AAV) initiator protein, Rep78, catalyzes the cleavage and ligation of single-stranded AAV ori DNA.
J. Virol.
74:3122-3129 |
| 50. |
Smith, R. H., and R. M. Kotin.
1998.
The Rep52 gene product of adeno-associated virus is a DNA helicase with 3'-to-5' polarity.
J. Virol.
72:4874-4881 |
| 51. | Smith, R. H., A. J. Spano, and R. M. Kotin. 1997. The Rep78 gene product of adeno-associated virus (AAV) self-associates to form a hexameric complex in the presence of AAV ori sequences. J. Virol. 71:4461-4471[Abstract]. |
| 52. |
Snyder, R. O.,
D. S. Im,
T. Ni,
X. Xiao,
R. J. Samulski, and N. Muzyczka.
1993.
Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein.
J. Virol.
67:6096-6104 |
| 53. |
Srivastava, A.,
E. W. Lusby, and K. I. Berns.
1983.
Nucleotide sequence and organization of the adeno-associated virus 2 genome.
J. Virol.
45:555-564 |
| 54. | Surosky, R. T., M. Urabe, S. G. Godwin, S. A. McQuiston, G. J. Kurtzman, K. Ozawa, and G. Natsoulis. 1997. Adeno-associated virus Rep proteins target DNA sequences to a unique locus in the human genome. J. Virol. 71:7951-7959[Abstract]. |
| 55. |
Tratschin, J. D.,
I. L. Miller, and B. J. Carter.
1984.
Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function.
J. Virol.
51:611-619 |
| 56. |
Urabe, M.,
Y. Hasumi,
A. Kume,
R. T. Surosky,
G. J. Kurtzman,
K. Tobita, and K. Ozawa.
1999.
Charged-to-alanine scanning mutagenesis of the N-terminal half of adeno-associated virus type 2 Rep78 protein.
J. Virol.
73:2682-2693 |
| 57. | Urcelay, E., P. Ward, S. M. Wiener, B. Safer, and R. M. Kotin. 1995. Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein. J. Virol. 69:2038-2046[Abstract]. |
| 58. | Walker, S. L., R. S. Wonderling, and R. A. Owens. 1997. Mutational analysis of the adeno-associated virus type 2 Rep68 protein helicase motifs. J. Virol. 71:6996-7004[Abstract]. |
| 59. | Ward, P., and K. I. Berns. 1996. In vitro replication of adeno-associated virus DNA: enhancement by extracts from adenovirus-infected HeLa cells. J. Virol. 70:4495-4501[Abstract]. |
| 60. |
Ward, P.,
F. B. Dean,
M. E. O'Donnell, and K. I. Berns.
1998.
Role of the adenovirus DNA-binding protein in in vitro adeno-associated virus DNA replication.
J. Virol.
72:420-427 |
| 61. |
Ward, P.,
E. Urcelay,
R. Kotin,
B. Safer, and K. I. Berns.
1994.
Adeno-associated virus DNA replication in vitro: activation by a maltose binding protein/Rep 68 fusion protein.
J. Virol.
68:6029-6037 |
| 62. | Weitzman, M. D., S. R. Kyostio, B. J. Carter, and R. A. Owens. 1996. Interaction of wild-type and mutant adeno-associated virus (AAV) Rep proteins on AAV hairpin DNA. J. Virol. 70:2440-2448[Abstract]. |
| 63. |
Weitzman, M. D.,
S. R. Kyostio,
R. M. Kotin, and R. A. Owens.
1994.
Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNA.
Proc. Natl. Acad. Sci. USA
91:5808-5812 |
| 64. | Wonderling, R. S., S. R. Kyostio, and R. A. Owens. 1995. A maltose-binding protein/adeno-associated virus Rep68 fusion protein has DNA-RNA helicase and ATPase activities. J. Virol. 69:3542-3548[Abstract]. |
| 65. |
Wu, J.,
M. D. Davis, and R. A. Owens.
1999.
Factors affecting the terminal resolution site endonuclease, helicase, and ATPase activities of adeno-associated virus type 2 Rep proteins.
J. Virol.
73:8235-8244 |
| 66. |
Yang, Q., and J. P. Trempe.
1993.
Analysis of the terminal repeat binding abilities of mutant adeno-associated virus replication proteins.
J. Virol.
67:4442-4447 |
| 67. | Young, S. M., Jr., W. Xiao, and R. J. Samulski. 2000. Site-specific targeting of DNA plasmids to chromosome 19 using AAV cis and trans sequences. Methods Mol. Biol. 133:111-126[Medline]. |
| 68. | Zadori, Z., R. Stefancsik, T. Rauch, and J. Kisary. 1995. Analysis of the complete nucleotide sequences of goose and muscovy duck parvoviruses indicates common ancestral origin with adeno-associated virus 2. Virology 212:562-573[CrossRef][Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»